# Amgen Inc. (AMGN) — Q4-2011 Earnings Results

**Report date:** 2012-01-26 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2011

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 1.6%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.21 | N/A | +1.26% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Neutral

Management expressed a steady outlook without offering detailed future projections. They emphasized the importance of their existing product lineup.

**Key quotes:**

> Management did not provide specific guidance for future quarters.

> The company remains focused on its core products and pipeline.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a slight beat on EPS, but the stock reacted negatively, dropping 1.6%. The lack of revenue data and forward guidance may have contributed to investor caution. Overall, the company appears stable but lacks clear direction for future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2011_